TRIANNI and Antibody Discovery

Fully human monoclonal antibodies are powerful biological therapeutics.

Among many options available for isolating them, TRIANNI’s technology is distinguished by key advantages of ease of use, antibody diversity, and in vivo selection.


Biologics & Biosimilars Congress

1-2 Febuary 2016 | Berlin, Germany

Biocom’s Global Life Science Partnering Conference

February 24–26 2016 | La Jolla, California, USA

Life Science Conference

March 1–2, 2016 | Raleigh, North Carolina, USA